Skip to content

YiChang HEC ChangJiang Pharmaceutical Co Ltd Sustainability Reports

The company develops, manufactures, and sells pharmaceutical products in China, specializing in anti-viral, endocrine, and metabolic drugs. Its primary core product is the anti-influenza drug Kewei (Oseltamivir Phosphate).

Sector: Manufacturing

Country: China

Exchange: Hong Kong Stock Exchange

FIGI: BBG00BNKGQK8

11 reports from 2016 to 2024